Liquid Biopsies and Imaging in Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

January 2, 2019

Primary Completion Date

May 16, 2022

Study Completion Date

May 16, 2022

Conditions
Breast Cancer
Interventions
DIAGNOSTIC_TEST

Liquid biopsy

A blood sample containing circulating tumor DNA and circulating tumor cells.

DIAGNOSTIC_TEST

Multi-parametric MRI

Multi-parametric MRI combines different imaging protocols in one session to measure more functional items than perfusion alone, addressing different aspects of tumor biology.

Trial Locations (1)

3584 CX

Universitair Medisch Centrum Utrecht, Utrecht

All Listed Sponsors
collaborator

Horizon 2020 - European Commission

OTHER

collaborator

Philips Electronics Nederland BV

INDUSTRY

collaborator

Agena Bioscience GmbH

UNKNOWN

collaborator

DiaDx

UNKNOWN

collaborator

Stilla Technologies

UNKNOWN

collaborator

ANGLE Europe Limited

UNKNOWN

collaborator

ALS Automated Lab Solutions GmbH

UNKNOWN

collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

collaborator

Philips GmbH Innovate Technologies

UNKNOWN

collaborator

Institut du Cancer de Montpellier - Val d'Aurelle

OTHER

lead

UMC Utrecht

OTHER

NCT04223492 - Liquid Biopsies and Imaging in Breast Cancer | Biotech Hunter | Biotech Hunter